FDA Orange Book
Generic for Rimactane
Rimactane contains rifampin. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Rimactane is rifampin. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Rimactane and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Rimactane products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, oral | 300MG | Marketed (Rx) | AB | 4 | AB |
NDA 050429, held by TP ANDA HOLDINGS LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic rifampin
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| EPIC PHARMA LLC | 064150 | AB (A-rated, therapeutically equivalent) | May 28, 1997 | 300MG |
| CHARTWELL MOLECULAR HOLDINGS LLC | 065390 | AB (A-rated, therapeutically equivalent) | March 28, 2008 | 300MG |
| LUPIN PHARMACEUTICALS INC | 090034 | AB (A-rated, therapeutically equivalent) | August 21, 2013 | 300MG |
| NOVITIUM PHARMA LLC | 219918 | AB (A-rated, therapeutically equivalent) | June 29, 2026 | 300MG |
Questions
Is there a generic for Rimactane?
Yes. The generic name for Rimactane is rifampin. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Rimactane?
The active ingredient in Rimactane is rifampin, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.